Treatments in Respiratory Medicine

1.4(top 50%)

impact factor

88(top 100%)

papers

2.9K(top 20%)

citations

34(top 20%)

h-index

1.5(top 50%)

impact factor

all documents

3.0K

doc citations

52(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The Role of Nuclear Factor Kappa B in the Pathogenesis of Pulmonary Diseases: Implications for Therapy	Treatments in Respiratory Medicine	2003	187
2	The Role of Interleukin-8 and its Receptors in Inflammatory Lung Disease	Treatments in Respiratory Medicine	2002	173
3	Prostanoids for Pulmonary Arterial Hypertension	Treatments in Respiratory Medicine	2003	123
4	Serotonin Agonists and Antagonists in Obstructive Sleep Apnea	Treatments in Respiratory Medicine	2003	121
5	Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis	Treatments in Respiratory Medicine	2003	119
6	Adverse Effects of β-Agonists	Treatments in Respiratory Medicine	2003	112
7	Inhaled Corticosteroids With/Without Long-Acting β-Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients	Treatments in Respiratory Medicine	2003	93
8	Diffuse Panbronchiolitis	Treatments in Respiratory Medicine	2002	88
9	Anti-Interleukin-5 Monoclonal Antibodies	Treatments in Respiratory Medicine	2003	75
10	Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma	Treatments in Respiratory Medicine	2003	69
11	Cefepime	Treatments in Respiratory Medicine	2003	67
12	Pseudomonal Infections in Patients with COPD	Treatments in Respiratory Medicine	2003	64
13	Legionnaires’ Disease	Treatments in Respiratory Medicine	2003	55
14	Pharmacotherapy of the Ion Transport Defect in Cystic Fibrosis	Treatments in Respiratory Medicine	2003	52
15	The Role of Defensins in Lung Biology and Therapy	Treatments in Respiratory Medicine	2002	50
16	Targeting Adenosine Receptors	Treatments in Respiratory Medicine	2002	50
17	Comparison of Intranasal Corticosteroids and Antihistamines in Allergic Rhinitis	Treatments in Respiratory Medicine	2003	47
18	Biology and Therapeutic Potential of the Interleukin-4/Interleukin-13 Signaling Pathway in Asthma	Treatments in Respiratory Medicine	2002	45
19	Recent Advances in the Management of Asthma Using Leukotriene Modifiers	Treatments in Respiratory Medicine	2003	45
20	The Etiology and Management of Pregnancy Rhinitis	Treatments in Respiratory Medicine	2003	44
21	Poor Sleep and Daytime Somnolence in Allergic Rhinitis	Treatments in Respiratory Medicine	2002	43
22	Sublingual Tacrolimus for Immunosuppression in Lung Transplantation	Treatments in Respiratory Medicine	2002	43
23	Is There a Place for Inhaled Nitric Oxide in the Therapy of Acute Pulmonary Embolism?	Treatments in Respiratory Medicine	2002	40
24	The Role of DOTS in Tuberculosis Treatment and Control	Treatments in Respiratory Medicine	2003	40
25	Psychiatric Factors in Asthma	Treatments in Respiratory Medicine	2003	40
26	Surfactant Therapy for Respiratory Distress Syndrome in Premature Neonates	Treatments in Respiratory Medicine	2002	37
27	Delivering Antibacterials to the Lungs	Treatments in Respiratory Medicine	2002	37
28	Obstructive Sleep Apnea in Children	Treatments in Respiratory Medicine	2002	37
29	The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease	Treatments in Respiratory Medicine	2002	36
30	Preventing Exacerbations of Chronic Bronchitis and COPD	Treatments in Respiratory Medicine	2003	36
31	Prevention and Treatment of Gastrointestinal Complications in Patients on Mechanical Ventilation	Treatments in Respiratory Medicine	2003	36
32	Treatment of Community-Acquired Lower Respiratory Tract Infections during Pregnancy	Treatments in Respiratory Medicine	2003	36
33	Recent Developments in the Treatment of Obstructive Sleep Apnea	Treatments in Respiratory Medicine	2003	36
34	Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma	Treatments in Respiratory Medicine	2002	35
35	Acute Asthma in Children and Adolescents	Treatments in Respiratory Medicine	2003	35
36	Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis	Treatments in Respiratory Medicine	2003	33
37	Eosinophilic Bronchitis	Treatments in Respiratory Medicine	2003	33
38	Pharmacotherapeutic Management of Pulmonary Sarcoidosis	Treatments in Respiratory Medicine	2003	32
39	Thromboxane A2 Inhibition	Treatments in Respiratory Medicine	2002	31
40	Second-Generation Antihistamines in Asthma Therapy	Treatments in Respiratory Medicine	2002	31
41	The Association of Gastroesophageal Reflux Disease with Asthma and Chronic Cough in the Adult	Treatments in Respiratory Medicine	2002	29
42	Asthma Refractory to Glucocorticoids	Treatments in Respiratory Medicine	2002	29
43	Formoterol	Treatments in Respiratory Medicine	2002	28
44	The Dilemma of Occupational Rhinitis	Treatments in Respiratory Medicine	2003	26
45	Management of Respiratory Failure in Status Asthmaticus	Treatments in Respiratory Medicine	2002	24
46	Idiopathic Pulmonary Fibrosis	Treatments in Respiratory Medicine	2002	24
47	Clarithromycin Extended-Release Tablet	Treatments in Respiratory Medicine	2003	24
48	Management of Malignancy-Associated Pleural Effusion	Treatments in Respiratory Medicine	2003	23
49	Clinical Usefulness of Inflammatory Markers in Asthma	Treatments in Respiratory Medicine	2003	23
50	Clinical Implications of Gastroesophageal Reflux Disease and Swallowing Dysfunction in COPD	Treatments in Respiratory Medicine	2003	22

Scientometrics

Overviews

Citing Bodies

Treatments in Respiratory Medicine

Top Articles